IP Library Assignment 059051/0284
Patent Assignment
Reel/Frame 059051/0284

Assignment of Assignor's Interest

Recorded: 2022-02-18 Pages: 5
Assignors
DAGGS, THOMAS A.
Executed: 2017-07-10
SHIELDS, PAUL P.
Executed: 2017-07-10
Assignee
ENTERIS BIOPHARMA, INC.
83 FULTON STREET, BOONTON, NEW JERSEY, 07005
Covered Property (1)
Room Temperature Stable Oral Calcitonin Formulation
Application: 17/675,643 →
Publication: US 2023/0000779
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 18, 2022
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 059051/0297 →
Assignment of Assignor's Interest Feb 18, 2022
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 059051/0340 →
Assignment of Assignor's Interest Jan 5, 2023
From: TAURUS DEVELOPMENT COMPANY LLC
To: PARK THERAPEUTICS, INC.
Reel/Frame 062287/0841 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment. Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →